Bernard F. Cole
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bernard F. Cole has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Richard D. Gelber
Dana-Farber Cancer Institute, Boston, MA
3 shared publications Alan M. Zaslavsky
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, U.S.A.
2 shared publications- Marco Bonetti
Bocconi University, Milan, Italy
2 shared publications Richard D. Gelber
Department of Biostatistics, Harvard School of Public Health and Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, U.S.A.
2 shared publicationsShari Gelber
Department of Biostatistical Science , Dana-Farber Cancer Institute , Boston, Massachusetts, USA
2 shared publicationsAlan S Coates
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 6 June 2007
- Published by American Medical Association (AMA) in JAMA
- Vol. 297 (21) , 2351-2359
Folic Acid for the Prevention of Colorectal Adenomas
Folic acid and its derivatives (folate) are essential nutrients in humans and play an important role in nucleotide synthesis and methylation reactions.1 Folate deficiency leads to macrocytic anemia, and abundant evidence indicates that even in well-nourished western populations, folate supplementation reduces the risk of neural tube defects.2
- 6 June 2007
- Published by American Medical Association (AMA) in JAMA
- Vol. 297 (21) , 2351-2359
Top Cited PapersOpen AccessFolic Acid for the Prevention of Colorectal Adenomas
Folic acid and its derivatives (folate) are essential nutrients in humans and play an important role in nucleotide synthesis and methylation reactions.1 Folate deficiency leads to macrocytic anemia, and abundant evidence indicates that even in well-nourished western populations, folate supplementation reduces the risk of neural tube defects.2
- 24 June 2005
- Published by Wiley in Statistics in Medicine
- Vol. 24 (15) , 2317-2334
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness
- 24 June 2005
- Published by Wiley in Statistics in Medicine
- Vol. 24 (15) , 2317-2334
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness
- 24 December 2004
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 14 (1) , 111-124
A Quality-Adjusted Survival (Q-TWiST) Model for Evaluating Treatments for Advanced Stage Cancer
Quality of life is an important component in the evaluation of therapies, especially in advanced cancer. Methods available for the analysis of longitudinal quality-of-life data include linear mixed models (including growth curve models), generalized linear models, generalized estimating equations, and joint modeling of quality of life and the missingness process. Quality-adjusted survival (Q-TWiST) has also been useful to compare treatments. By weighting the durations of health states according to their quality of life, one arrives at a single end point reflecting the duration of survival and the quality of life. We propose methods for incorporating longitudinal quality-of-life data into quality-adjusted survival. We divide follow-up time into two states, “poor” and “good,” based on a cut-off applied to observed quality-of-life scores. Disease progression is handled as a separate state. We then use survival analysis methods to estimate the mean duration of each state as well as mean quality-adjus...
- 24 December 2004
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 14 (1) , 111-124
A Quality-Adjusted Survival (Q-TWiST) Model for Evaluating Treatments for Advanced Stage Cancer
Quality of life is an important component in the evaluation of therapies, especially in advanced cancer. Methods available for the analysis of longitudinal quality-of-life data include linear mixed models (including growth curve models), generalized linear models, generalized estimating equations, and joint modeling of quality of life and the missingness process. Quality-adjusted survival (Q-TWiST) has also been useful to compare treatments. By weighting the durations of health states according to their quality of life, one arrives at a single end point reflecting the duration of survival and the quality of life. We propose methods for incorporating longitudinal quality-of-life data into quality-adjusted survival. We divide follow-up time into two states, “poor” and “good,” based on a cut-off applied to observed quality-of-life scores. Disease progression is handled as a separate state. We then use survival analysis methods to estimate the mean duration of each state as well as mean quality-adjus...
- 1 May 2003
- Vol. 12 (5) , 464-7
Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.
Several studies have suggested that selenium may help to prevent colorectal neoplasia. To investigate the relation between prediagnostic serum selenium concentrations and colorectal adenomas, we conducted a nested case-control study using data from a large, multicenter, adenoma prevention trial. Cases comprised a total of 276 patients who developed a colorectal adenoma between the year 1 and year 4 follow-up exam. Controls were 276 patients who did not develop an adenoma during this time interval, matched to case subjects on age, sex, and clinical center. Total and bound selenium concentrations were measured from baseline or year 1 serum samples using instrumental neutron activation analysis. We estimated the odds ratios of colorectal adenoma in relation to serum selenium concentrations adjusting for age, clinical center, and sex. Compared with the lowest quintile, the odds ratio for the highest quintile was 0.76 (95% confidence interval, 0.44-1.30) for total selenium and 0.60 (95% confidence interval, 0.34-1.05) for bound selenium, and there was no apparent trend in risk (P for trend = 0.50 for total selenium and P for trend = 0.20 for bound selenium). Thus, our findings do not indicate a clear association between serum selenium concentrations and adenoma recurrence.
- 1 May 2003
- Vol. 12 (5) , 464-7
Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.
Several studies have suggested that selenium may help to prevent colorectal neoplasia. To investigate the relation between prediagnostic serum selenium concentrations and colorectal adenomas, we conducted a nested case-control study using data from a large, multicenter, adenoma prevention trial. Cases comprised a total of 276 patients who developed a colorectal adenoma between the year 1 and year 4 follow-up exam. Controls were 276 patients who did not develop an adenoma during this time interval, matched to case subjects on age, sex, and clinical center. Total and bound selenium concentrations were measured from baseline or year 1 serum samples using instrumental neutron activation analysis. We estimated the odds ratios of colorectal adenoma in relation to serum selenium concentrations adjusting for age, clinical center, and sex. Compared with the lowest quintile, the odds ratio for the highest quintile was 0.76 (95% confidence interval, 0.44-1.30) for total selenium and 0.60 (95% confidence interval, 0.34-1.05) for bound selenium, and there was no apparent trend in risk (P for trend = 0.50 for total selenium and P for trend = 0.20 for bound selenium). Thus, our findings do not indicate a clear association between serum selenium concentrations and adenoma recurrence.
- 1 July 2001
- Published by Elsevier in The Lancet
- Vol. 358 (9278) , 277-286
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis
- 1 July 2001
- Published by Elsevier in The Lancet
- Vol. 358 (9278) , 277-286
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis
- 1 December 1999
- Published by JSTOR in Journal of the American Statistical Association
- Vol. 94 (448) , 1025
A Method-of-Moments Estimation Procedure for Categorical Quality-of-Life Data with Nonignorable Missingness
Quality-of-life outcomes collected during clinical trials often have considerable amounts of missing data, which, if not appropriately accounted for, may lead to bias in inferences. We introduce a method-of-moments (MM) estimating procedure for a model designed to handle nonignorable missingness arising in categorical data measured on independent populations. The missingness mechanism is assumed to be the same across the populations. We derive necessary and sufficient conditions for the identifiability of the model and fit the model to quality-of-life data collected as part of a breast cancer clinical trial. We compare the MM estimator to the maximum likelihood estimator in a simulation study.
- 1 December 1999
- Published by JSTOR in Journal of the American Statistical Association
- Vol. 94 (448) , 1025
A Method-of-Moments Estimation Procedure for Categorical Quality-of-Life Data with Nonignorable Missingness
Quality-of-life outcomes collected during clinical trials often have considerable amounts of missing data, which, if not appropriately accounted for, may lead to bias in inferences. We introduce a method-of-moments (MM) estimating procedure for a model designed to handle nonignorable missingness arising in categorical data measured on independent populations. The missingness mechanism is assumed to be the same across the populations. We derive necessary and sufficient conditions for the identifiability of the model and fit the model to quality-of-life data collected as part of a breast cancer clinical trial. We compare the MM estimator to the maximum likelihood estimator in a simulation study.
- 1 December 1995
- Published by JSTOR in Journal of the American Statistical Association
- Vol. 90 (432) , 1364
An Empirical Bayes Model for Markov-Dependent Binary Sequences with Randomly Missing Observations
We develop an improved empirical Bayes estimation methodology for the analysis of two-state Markov chains observed from heterogeneous individuals. First, the two transition probabilities corresponding to each chain are assumed to be drawn from a common, bivariate distribution that has beta marginals. Second, randomly missing observations are incorporated into the likelihood for the hyperparameters by efficiently summing over all possible values for the missing observations. A likelihood ratio test is used to test for dependence between the transition probabilities. Posterior distributions for the transition probabilities are also derived, as is an approximation for the equilibrium probabilities. The proposed procedures are illustrated in a numerical example and in an analysis of longitudinal store display data.
- 1 December 1995
- Published by JSTOR in Journal of the American Statistical Association
- Vol. 90 (432) , 1364
An Empirical Bayes Model for Markov-Dependent Binary Sequences with Randomly Missing Observations
We develop an improved empirical Bayes estimation methodology for the analysis of two-state Markov chains observed from heterogeneous individuals. First, the two transition probabilities corresponding to each chain are assumed to be drawn from a common, bivariate distribution that has beta marginals. Second, randomly missing observations are incorporated into the likelihood for the hyperparameters by efficiently summing over all possible values for the missing observations. A likelihood ratio test is used to test for dependence between the transition probabilities. Posterior distributions for the transition probabilities are also derived, as is an approximation for the equilibrium probabilities. The proposed procedures are illustrated in a numerical example and in an analysis of longitudinal store display data.
- 1 May 1995
- Published by JSTOR in The American Statistician
- Vol. 49 (2) , 161
Comparing Treatments Using Quality-Adjusted Survival: The Q-Twist Method
- 1 May 1995
- Published by JSTOR in The American Statistician
- Vol. 49 (2) , 161
Comparing Treatments Using Quality-Adjusted Survival: The Q-Twist Method
- 1 September 1994
- Published by JSTOR
- Vol. 50 (3) , 621
Parametric Approaches to Quality-Adjusted Survival Analysis
We present a parametric methodology for performing quality-of-life-adjusted survival analysis using multivariate censored survival data. It represents a general...
- 1 September 1994
- Published by JSTOR
- Vol. 50 (3) , 621
Parametric Approaches to Quality-Adjusted Survival Analysis
We present a parametric methodology for performing quality-of-life-adjusted survival analysis using multivariate censored survival data. It represents a general...